Experts from the U.S. Food and Drug Administration (FDA) discuss important new drug information as well as urgent insights about approved drug products.
All content for FDA Drug Information Updates is the property of ReachMD and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Experts from the U.S. Food and Drug Administration (FDA) discuss important new drug information as well as urgent insights about approved drug products.
FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease
FDA Drug Information Updates
8 years ago
FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease
FDA medical oncologists discuss the July 7, 2017, approval of l-glutamine to reduce the acute complications of sickle cell disease.
Released August 17, 2017
FDA Drug Information Updates
Experts from the U.S. Food and Drug Administration (FDA) discuss important new drug information as well as urgent insights about approved drug products.
